Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:EC 6.3.5.2 [GMP synthase (glutamine-hydrolysing)] inhibitor
go back to main search page
Accession:CHEBI:138928 term browser browse the term
Definition:An EC 6.3.5.* (carbon-nitrogen ligases with glutamine as amido-N-donor) inhibitor that interferes with the action of GMP synthase (glutamine-hydrolysing) (EC 6.3.5.2).
Synonyms:related_synonym: EC 6.3.5.2 [GMP synthase (glutamine-hydrolysing)] inhibitors;   EC 6.3.5.2 inhibitor;   EC 6.3.5.2 inhibitors;   GMP synthase (glutamine-hydrolysing) inhibitor;   GMP synthase (glutamine-hydrolysing) inhibitors;   GMP synthetase (glutamine-hydrolysing) inhibitor;   GMP synthetase (glutamine-hydrolysing) inhibitors;   guanosine 5'-monophosphate synthetase inhibitor;   guanosine 5'-monophosphate synthetase inhibitors;   guanosine monophosphate synthetase (glutamine-hydrolyzing) inhibitor;   guanosine monophosphate synthetase (glutamine-hydrolyzing) inhibitors;   guanylate synthetase (glutamine-hydrolyzing) inhibitor;   guanylate synthetase (glutamine-hydrolyzing) inhibitors;   xanthosine 5'-phosphate amidotransferase inhibitor;   xanthosine 5'-phosphate amidotransferase inhibitors;   xanthosine-5'-phosphate:L-glutamine amido-ligase (AMP-forming) inhibitor;   xanthosine-5'-phosphate:L-glutamine amido-ligase (AMP-forming) inhibitors


show annotations for term's descendants       view all columns           Sort by:
 

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19749
    role 19696
      biological role 19694
        biochemical role 19192
          enzyme inhibitor 18089
            EC 6.* (ligase) inhibitor 1393
              EC 6.3.* (C-N bond-forming ligase) inhibitor 313
                EC 6.3.5.* (carbon-nitrogen ligases with glutamine as amido-N-donor) inhibitor 0
                  EC 6.3.5.2 [GMP synthase (glutamine-hydrolysing)] inhibitor 0
                    6-diazo-5-oxo-L-norleucine 0
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.